Clinical trial
Prospective, Multicenter, Single Blind, Randomized Study Comparing the EndoMAXX Endoluminal Valve Technology (EVT) Fully Covered Esophageal Stent With Valve to the EndoMAXX Fully Covered Esophageal Stent for Malignant Strictures Requiring Stent Placement Across the Gastroesophageal Junction
NCT02159898 is registered in ClinicalTrials.gov with Merit Medical Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multicenter, Single Blind, Randomized Study Comparing the EndoMAXX Endoluminal Valve Technology (EVT) Fully Covered Esophageal Stent With Valve to the EndoMAXX Fully Covered Esophageal Stent for Malignant Strictures Requiring Stent Placement Across the Gastroesophageal Junction
- Lead sponsor
- Merit Medical Systems, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- December 31, 2016
- Enrollment
- 60 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
malignant esophageal strictures